A Family Attributes Their Son’s Tragic Death to Tamiflu

An Indiana family is raising awareness about the potential risks associated with the antiviral medication Tamiflu, which they believe may have contributed to their teenage son’s tragic decision to take his life. The family’s concerns stem from the recent passing of 16-year-old Jason Mitchell, who was prescribed Tamiflu after being diagnosed with influenza. Just days after starting the medication, Jason’s uncle discovered him unresponsive in the family garage.

Jason’s Story

Jason’s aunt and guardian, Linda Carter, described him as a vibrant and cheerful young man who was always smiling. Following his flu diagnosis, Linda quickly got Jason started on Tamiflu, believing it would help alleviate his symptoms. “We didn’t want to waste any time,” she explained. However, the very next day, after not receiving a text reply from Jason, Linda began to feel uneasy. “I knew something was off. When my husband came home, he found Jason,” she recounted.

Linda’s husband, Tom, reflected on the situation, saying, “We were left wondering what had changed. Jason had been his usual self until he started this new medication.” The family was taken aback by the sudden turn of events, noting that Jason had only taken two doses of Tamiflu and exhibited no prior signs of depression or suicidal thoughts. He was thriving academically and actively participating in the wrestling team.

FDA Warnings and Family Concerns

The FDA has issued warnings regarding Tamiflu, particularly for children and adolescents who may be at an increased risk for neuropsychiatric symptoms such as confusion and unusual behavior. These serious side effects can manifest shortly after beginning treatment or may occur with the flu itself. Individuals taking Tamiflu are advised to be monitored for any atypical behaviors, and healthcare providers should be notified immediately if any arise.

Linda expressed her fears, stating, “It’s heart-wrenching to think that another family might unknowingly put their child at risk by giving them this medication.” This is why the family has chosen to speak out about Jason’s untimely death.

Manufacturer’s Statement

In a statement to the media, the manufacturer of Tamiflu acknowledged that neuropsychiatric events have been reported in patients with influenza, particularly in younger populations. While they cannot provide specific details regarding Jason’s case, they pledged to conduct a comprehensive investigation into the circumstances surrounding his death.

Current Flu Season Statistics

This flu season has been notably severe, with over 37 pediatric fatalities reported thus far. Although the exact cause of Jason’s death remains uncertain, the CDC recommends Tamiflu for certain patients, emphasizing that it should only be administered to those meeting specific criteria.

Support for Jason’s Family

To assist with funeral expenses and to establish a scholarship in Jason’s memory, a GoFundMe page has been set up. For more information on topics related to home insemination, consider visiting intracervicalinsemination.com or exploring resources on pregnancy at womenshealth.gov. Additionally, for those interested in enhancing fertility, check out Make a Mom.

Conclusion

In summary, the family of Jason Mitchell is advocating for awareness regarding the potential side effects of Tamiflu following their son’s tragic death. They emphasize the need for careful monitoring when administering this medication to young patients.